SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: Boris Maleshev who wrote (3681)11/8/2000 11:55:52 AM
From: Marty R  Read Replies (1) | Respond to of 5665
 
Boris,

I didn't expect such a response from the announcement on preclinicals for huN901-DM1 (Small cell lung cancer). But, the fact that these trials echo good results similar to those found with huC242-DM1 (Colon, pancreatic & non small cell lung cancer) is a very good indication about the science and technology being used.

Anxious to see how news on human trials (especially if as good as hoped) will be received.